Imodium

Loperamide Hydrochloride, the active ingredient in Imodium, is an antidiarrheal presented as an oral tablet for oral use. It treats acute nonspecific diarrhea, chronic diarrhea linked to inflammatory bowel disease, and irritable bowel syndrome with diarrhea.

GNH USA supplies Imodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium (loperamide hydrochloride) acts on the gastrointestinal tract to reduce stool frequency and liquidity.

- Acute nonspecific diarrhea: reduces stool frequency and improves stool consistency. - Chronic diarrhea associated with inflammatory bowel disease: helps maintain hydration and lessen bowel movements. - Irritable bowel syndrome with diarrhea (IBS‑D): alleviates frequent loose stools and abdominal urgency.

Common side effects are generally mild and related to reduced gut motility.

Common Side Effects: - Constipation: hard, infrequent stools. - Nausea: mild stomach upset. - Abdominal cramps: occasional discomfort. - Dry mouth: reduced salivation. - Dizziness: light‑headed sensation. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Severe constipation or intestinal obstruction: may require medical attention. - Paralytic ileus: rare loss of bowel movement. - Toxic megacolon: severe colonic dilation. - Allergic reactions: rash, itching, swelling. - Cardiac arrhythmias: very rare QT prolongation. - Central nervous system effects: faintness or confusion in overdose.

Before using Imodium, consider the following safety measures.

- Indication verification: ensure diarrhea is not caused by infection with fever or blood. - Hypersensitivity: avoid if you have known allergy to loperamide or excipients. - Hepatic impairment: use with caution; dose may need adjustment. - Concomitant opioids: avoid combined use to prevent additive effects on gut motility. - Pediatric use: not recommended for children under a specified age without medical advice. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Loperamide may interact with other medicines that affect its metabolism or gut motility.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise loperamide plasma levels and increase risk of cardiac toxicity. - Other antidiarrheal agents: additive slowing of intestinal transit may cause severe constipation. - Opioid analgesics: combined central and peripheral opioid effects may lead to respiratory depression in overdose.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness of loperamide. - Anticholinergic drugs: may enhance dry‑mouth and constipation. - Antidepressants affecting serotonin: monitor for rare serotonin syndrome when high doses are used.